As of 2026-10-07, the Relative Valuation of Genomic Vision SA (GV.PA) is (0.37) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 EUR, the upside of Genomic Vision SA based on Relative Valuation is -20668.0%.
The range of the Relative Valuation is (0.31) - (0.37) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 15.3x | 15.1x |
| Forward P/E multiples | 11.3x - 13.5x | 11.8x |
| Fair Price | (0.31) - (0.37) | (0.37) |
| Upside | -17410.8% - -20775.1% | -20668.0% |
| Date | P/E |